9Kawasaki H, Isoyama K, Eguchi M, et al. Superior outcome of infant acute myeloid leukemia with intensive chemotherapy : results of the Japan Infant Leukemia Study Group. Blood, 2001 ;98 (13): 3589-3594. 被引量：1
10Ishii E, Kawasaki H, Isoyama K, et al. Recent advances in the treatment of infant acute myeloid leukemia. Leuk Lymphoma, 2003 ;44 ( 5 ) : 741-748. 被引量：1
2Pui CH,Kalwinsky DK,Schell MJ,et al.Acute nonlymphocyte leukemia in infants:clinical presentation and outcome.J Clin Oncol,1998,6 :1008-1013. 被引量：1
3Gurney J G, Ross J A, Wall D A, et al. Infant cancer in the U. S: histology-specific incidence and trends,1973 to 1992. J Padiatr Hematol Oncol, 1997, 19:428-432. 被引量：1
4Bresters D, Reus A C, Veerman, et al. Congenital leukemia:: the Dutch experience and review of the literature. Br J Haematol, 2002, 117:513-524. 被引量：1
5Hunger S P, Cleary, Repp R, et al. Backtracking leukemia to birth.: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci USA, 1997, 94:13950-13954. 被引量：1
6Reaman G H, Sposto R, Sensel M G, et al. Treatment outcome and prognostic factors for infants with acutelymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group. J Clin Oncol, 1999,19:35-42. 被引量：1
7Pui C H, Kalwinsky D K, Schell M J, et al. Acute nonlymphoblastic leukemia in infants:Clinical presentation and outcome. J Clin Oncol, 1988, 6:1008-1013. 被引量：1
8Frankel L S, Ochs J, Shuster J J, et al. Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience. J Pediatric Hematol Oncol, 1997, 19:35-42. 被引量：1
9Dordelmann M, Reiter A, Borkhardt A, et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood,1999, 94:1209-1217. 被引量：1
10Lauer S J, Camitta B M, Leventhal B G, et al. Intentive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: a Pediatric Oneology Group pilot study. J Pediatric Hematol Oncol, 1998, 20:229-233. 被引量：1
3Zweidler - Mckay PA, Hilden JM. The ABCs of infant leukemia [ J ]. Curr Probl Padiatr Adolese Health Care, 2008,38 ( 3 ) :78 - 94. 被引量：1
4Biondi A, Cimino G, Pieters R, et al. Biological and therapeutic insights of infant leukemia [ J ]. Blood,2000,96 ( 1 ) : 24 - 33. 被引量：1
5Pui C. Treatment of acute leukemias : New directions for clinical research [ M]. Totowa (NJ) : Humana Press,2003:75 -83. 被引量：1
6Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukemias [ J ]. Leukemia, 1995,9 (5) :762 - 769. 被引量：1
7Pieters R, Sehrappe M, de Lorenzo P, et al. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukemia ( interfant - 99 ) : An observational study and a multieentre randomised trial [ J ]. Lancet,2007,370 ( 9583 ) :240 - 250. 被引量：1
8Borkhardt A, Wuchter C, Viehmann S, et al. Infant acute lymphoblastic leukemia - combined cytogenetic, immunophenotypical and molecular analysis of 77 cases [ J ]. Leukemia, 2002,16 ( 9 ) : 1685 - 1690. 被引量：1
9Pieters R, den Boer ML, Durian M,et al. Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lym- phoblastic leukemia implications for treatment of infants [J]. Leukemia,1998,12(9) :1344 - 1348. 被引量：1
10Austin GE,Alvarado CS, Austin ED, et al. Prevalence of myeloperoxidase gene expression in infant acute lymphocytic leukemia [J]. Am J Clin Pathol, 1998,110 (5) :575 - 581. 被引量：1
